Diet drug controversy as US approves meds rejected by Europe

Diet drug controversy as US approves meds rejected by Europe
The decision from the Food and Drug Administration (FDA) to allow two anti-obesity drugs to be marketed in the US has been called into question by a senior doctor publishing in the BMJ. Dr. Sidney Wolfe, founder of the health research group at Public Citizen, says that the fact these drugs have been banned by the European regulator "puts the FDA to shame...